tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MRKR Stock Latest News

Marker Therapeutics files to sell 10.06M shares of common stock for holders
The FlyMarker Therapeutics files to sell 10.06M shares of common stock for holders
21d ago
MRKR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
MRK
NVO
Marker Therapeutics sells 5.03M shares at $3.20 in private placement
PremiumThe Fly
Marker Therapeutics sells 5.03M shares at $3.20 in private placement
1M ago
MRKR
Marker Therapeutics provides update on MT-601 patients
PremiumThe Fly
Marker Therapeutics provides update on MT-601 patients
1M ago
MRKR
Marker Therapeutics awarded $9.5M grant from CPRIT
PremiumThe Fly
Marker Therapeutics awarded $9.5M grant from CPRIT
2M ago
MRKR
Marker Therapeutics files $300M mixed securities shelf
PremiumThe FlyMarker Therapeutics files $300M mixed securities shelf
2M ago
MRKR
Marker Therapeutics Advances in Clinical Trials and Finances
Premium
Company Announcements
Marker Therapeutics Advances in Clinical Trials and Finances
3M ago
MRKR
Marker Therapeutics price target raised to $19 from $11 at Ladenburg
Premium
The Fly
Marker Therapeutics price target raised to $19 from $11 at Ladenburg
3M ago
MRKR
Marker Therapeutics Excels in Lymphoma Treatment Study
PremiumCompany Announcements
Marker Therapeutics Excels in Lymphoma Treatment Study
6M ago
MRKR
Marker Therapeutics Receives $2M NIH Grant for Lymphoma Study
PremiumCompany Announcements
Marker Therapeutics Receives $2M NIH Grant for Lymphoma Study
6M ago
MRKR
Marker Therapeutics awarded $2M grant from NIH SBIR program
PremiumThe Fly
Marker Therapeutics awarded $2M grant from NIH SBIR program
6M ago
MRKR
Marker Therapeutics’ Promising Cancer Therapy Progress
PremiumCompany Announcements
Marker Therapeutics’ Promising Cancer Therapy Progress
9M ago
MRKR
Marker Therapeutics initiated with a Buy at Ladenburg on post-CAR-T opportunity
PremiumThe FlyMarker Therapeutics initiated with a Buy at Ladenburg on post-CAR-T opportunity
9M ago
MRKR
Marker Therapeutics initiated with a Buy at Ladenburg
Premium
The Fly
Marker Therapeutics initiated with a Buy at Ladenburg
9M ago
MRKR
Marker Therapeutics’ MT-601 Shows Promising Results
Premium
Company Announcements
Marker Therapeutics’ MT-601 Shows Promising Results
10M ago
MRKR
Marker Therapeutics announces presentation on Phase 1 APOLLO study
PremiumThe Fly
Marker Therapeutics announces presentation on Phase 1 APOLLO study
10M ago
MRKR
Marker Therapeutics Advances in Immuno-Oncology
PremiumCompany Announcements
Marker Therapeutics Advances in Immuno-Oncology
10M ago
MRKR
Marker Therapeutics Ends Stock Sale Deal with LPC
PremiumCompany Announcements
Marker Therapeutics Ends Stock Sale Deal with LPC
11M ago
8K
MRKR
Marker receives approval from the USAN council, INN committee for neldaleucel
PremiumThe Fly
Marker receives approval from the USAN council, INN committee for neldaleucel
1y ago
MRKR
Marker Therapeutics announces clinical program updates, pipeline prioritization
PremiumThe FlyMarker Therapeutics announces clinical program updates, pipeline prioritization
1y ago
MRKR
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
MOR
ACHV
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
MOR
BPMC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >